Monday - May 25, 2026
Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder
April 22, 2026
MEMPHIS, Tennessee, April 22 [Category: BizHospital] -- St. Jude Children's Research Hospital issued the following news release:

* * *

Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder

*

Scientists at St. Jude Children's Research Hospital have found they can reverse the effects of HNRNPH2 -related neurodevelopmental disorder using antisense oligonucleotides (ASOs) in preclinical models. ASOs are s . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products